The Multiple Myeloma
The second most common hematologic malignancy is the clonal proliferation of neoplastic plasma cells within the bone marrow. There is the presence of monoclonal immunoglobulins in the serum and/or urine. This results in anemia, myelosuppression, bone destruction, and clinical consequences of para-p...
Saved in:
| Main Authors: | Keivan Daneshvar, Wolfram Andreas Bosbach, Nando Mertineit, Gerd Nöldge, Frank Mosler |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SJORANM GmbH (Ltd.)
2024-03-01
|
| Series: | Swiss Journal of Radiology and Nuclear Medicine |
| Subjects: | |
| Online Access: | https://sjoranm.com/sjoranm/article/view/21 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Presentation of extramedullary myeloma manifestations on B-mode (B-US) and contrast-enhanced ultrasound (CEUS)
by: Trenker Corinna, et al.
Published: (2025-05-01) -
Selinexor combined with bortezomib, lenalidomide, and dexamethasone for the treatment of newly diagnosed multiple myeloma with extramedullary disease
by: Junjing Yin, et al.
Published: (2024-11-01) -
Subglottic extramedullary plasmacytoma in a patient with multiple myeloma
by: Eva M. Ruis de Gauna Martin, et al.
Published: (2013-03-01) -
Anaplastic Multiple Myeloma Presenting as Acute Liver Failure: A Case Report
by: Yasmin O. Ali, et al.
Published: (2025-01-01) -
COMMD3 Regulates Copper Metabolism via the ATOX1-ATP7A-LOX Axis to Promote Multiple Myeloma Progression
by: Yajun Wang, et al.
Published: (2025-02-01)